Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma
Clinical trial NCT01052142 · COMPLETED
Trial details
- NCT number
- NCT01052142
- Sponsor
- Lipotek Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2012-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.